一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Circulatory system drugs>Angina Pectoris Drugs>Urapidil
Urapidil
  • Urapidil

Urapidil

Price $158.7 $4444.4
Package 1g/Bag 1Kg/Bag
Min. Order: 1g/Bag
Supply Ability: 80kg
Update Time: 2021-11-02

Product Details

Product Name: Urapidil CAS No.: 34661-75-1
Min. Order: 1g/Bag Purity: 99%
Supply Ability: 80kg Release date: 2021/11/02

English Name: urapidil

CAS No.: 34661-75-1

Molecular formula: c20h29n5o3

Molecular weight: 387.48

EINECS No.: 252-130-4

Clinical application:

1. All kinds of hypertension

(1) The effect of URA on essential hypertension is significant, and the effect of URA on reducing systolic blood pressure is more obvious, the impact on heart rate is minimal, the incidence of adverse reactions is low, and patients can tolerate it.

(2) SBP, DBP and HR of patients with severe hypertension after URA were significantly lower than those before URA. Compared with sodium nitroprusside, nitroglycerin and phentolamine, URA has the greatest advantage.

(3) The antihypertensive effect of URA is rapid and effective for hypertension caused by various reasons. The symptoms of URA group were improved well, and there were no side effects such as orthostatic hypotension, flushing and palpitation in phentolamine group.

(4) Pulmonary hypertension α 1 receptor is widely present in the pulmonary vascular bed and blocked by URA α In order to maintain or increase arterial partial pressure, it is necessary to reduce pulmonary arterial pressure, avoid vasodilation in hypoxic area, and not aggravate functional arteriovenous shunt. The results showed that the total effective rate of URA in the treatment of pulmonary hypertension, heart failure and pulmonary heart disease was 91.66%, P (O 2) increased by 25.31%, mean pulmonary artery pressure and pulmonary capillary incarcerated pressure decreased significantly, decreased by 28.74% and 35.62% respectively. At the same time, the product of systolic blood pressure and heart rate also decreased, reflecting the decrease of myocardial oxygen consumption, which is conducive to myocardial protection.

2. All kinds of heart failure

(1) Acute left heart failure was treated with ura25 mg and normal saline 10 ml, IV, 5 min. After that, ura112.5mg was added with 500ml 5% glucose for intravenous drip. Results URA significantly reduced SBP, DBP and HR, and the product of SBP and HR in patients with acute left heart failure. The blood pressure decreased significantly from 5 to 15 minutes after administration, and reached the lowest point at 60 minutes. Compared with before administration, SBP and DBP decreased by 26.8% and 24.6% respectively. The left ventricular systolic function was improved significantly. It has been reported that URA is superior to nitroglycerin in the treatment of acute left heart failure. The total effective rate of URA was 97% in 69 patients and 80% in nitroglycerin. The side effects of URA were less.

(2) Patients with congestive heart failure (CHF) were treated with ura12.5-25mg + 20ml normal saline, IV for 3-5min, followed by 50-100mg URA + 250-500ml 5% glucose. Results the effective rate of URA in improving heart function of patients with congestive heart failure was 92%, and the clinical symptoms were significantly improved. At the same time, URA directly dilated renal vessels, increased renal vascular perfusion and improved renal function, so that the blood and urine after heart failure was corrected β 2-mg decreased.


Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$33.00
VIP4Y
TargetMol Chemicals Inc.
2026-06-02
$33.00
VIP2Y
TargetMol Chemicals Inc.
2026-06-02
$40.00
Hebei Yanxi Chemical Co., Ltd.
2025-06-20
airuikechemical co., ltd.
2024-12-24
VIP7Y
Shaanxi Dideu Medichem Co. Ltd
2020-05-12
$1.00
VIP9Y
Career Henan Chemical Co
2019-07-06
$47.00
VIP2Y
TargetMol Chemicals Inc.
2025-04-30
  • Since: 2018-09-06
  • Address: Room B801, Financial Plaza, Jintai District, Baoji, Shaanxi, CN
INQUIRY
通城县| 乐都县| 花莲县| 连云港市| 同江市| 增城市| 吴川市| 台安县| 五河县| 镇康县| 连江县| 凤翔县| 余干县| 乌兰县| 平湖市| 渝北区| 锡林郭勒盟| 凤翔县| 平塘县| 壶关县| 龙胜| 电白县| 泸溪县| 桐城市| 舟山市| 天峨县| 改则县| 成安县| 诸暨市| 阳城县| 天等县| 榆林市| 酉阳| 曲沃县| 乌拉特后旗| 威海市| 邹城市| 鄂托克旗| 桂林市| 菏泽市| 乌拉特后旗|